Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 18, 2026, 4:00 PM EST
Endonovo Therapeutics Market Cap
Endonovo Therapeutics has a market cap or net worth of $180.76 thousand as of August 19, 2026. Its market cap has decreased by -25.10% in one year.
Market Cap
180.76K
Enterprise Value
n/a
Revenue
255.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 180.76K, an increase of 129.10%. That is a compound annual growth rate of 6.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 180.76K | - |
| Dec 31, 2025 | 180.76K | -16.91% |
| Dec 31, 2024 | 217.55K | -92.16% |
| Dec 29, 2023 | 2.77M | -20.72% |
| Dec 30, 2022 | 3.50M | 211.37% |
| Dec 31, 2021 | 1.12M | 127.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovation Pharmaceuticals | 264.38K |
| RegeneRx Biopharmaceuticals | 260.99K |
| Regen BioPharma | 234.79K |
| Ocean Biomedical | 232.37K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 160.58K |
| GB Sciences | 158.82K |
| Affymax | 119.18K |